Kennedy Capital Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.68M Sell
644,150
-12,108
-2% -$69.6K 0.07% 369
2026
Q1
$4.12M Sell
656,258
-17,662
-3% -$164K 0.09% 326
2025
Q4
$8.26M Sell
673,920
-998
-0.1% -$16.3K 0.18% 197
2025
Q3
$13.8M Buy
674,918
+202,446
+43% +$3.21M 0.31% 111
2025
Q2
$6.38M Sell
472,472
-5,932
-1% -$64.9K 0.15% 239
2025
Q1
$4.14M Sell
478,404
-115,596
-19% -$707K 0.1% 319
2024
Q4
$2.89M Buy
594,000
+217,676
+58% +$1.22M 0.06% 444
2024
Q3
$2.91M Buy
376,324
+42,127
+13% +$374K 0.06% 434
2024
Q2
$3.34M Buy
334,197
+14,398
+5% +$158K 0.07% 420
2024
Q1
$3.89M Sell
319,799
-170,886
-35% -$2.48M 0.08% 382
2023
Q4
$7.02M Sell
490,685
-64,990
-12% -$624K 0.15% 240
2023
Q3
$4.32M Buy
+555,675
New +$6.05M 0.11% 318
2023
Q1
Sell
-274,917
Closed -$4.62M 638
2022
Q4
$4.62M Sell
274,917
-131,783
-32% -$2.28M 0.13% 287
2022
Q3
$6.03M Buy
+406,700
New +$8.04M 0.18% 201
2020
Q3
Sell
-133,075
Closed -$1.73M 669
2020
Q2
$1.73M Buy
133,075
+102,625
+337% +$1.12M 0.05% 518
2020
Q1
$276K Buy
+30,450
New +$289K 0.01% 637

Other funds holding OPRX

Kennedy Capital Management's OPRX Position: Q2 2026 in Review

Kennedy Capital Management reduced its OptimizeRx (OPRX) stake by 1.8% in Q2 2026, selling an estimated $69.6K and leaving 644,150 shares worth $3.68M. The position accounts for 0.07% of the portfolio, ranked #369.

Kennedy Capital Management first reported a position in OPRX in Q1 2020 and has held it in 16 quarters since. The position peaked at $13.8M in Q3 2025. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Kennedy Capital Management held 644,150 shares of OptimizeRx worth $3.68M as of Q2 2026.
  • Kennedy Capital Management sold 12,108 OptimizeRx shares in Q2 2026, an estimated $69.6K.
  • OptimizeRx made up 0.07% of Kennedy Capital Management's portfolio in Q2 2026, its #369 holding.
  • Kennedy Capital Management first reported a position in OptimizeRx in Q1 2020 and has held it in 16 quarters since.
  • Kennedy Capital Management's OptimizeRx position peaked at $13.8M in Q3 2025.
  • 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.